Computer Enabled Neuroplasticity Treatment : A Clinical Trial of a Novel Design for Neurofeedback Therapy in Adult ADHD

Show full item record



Permalink

http://hdl.handle.net/10138/173548

Citation

Cowley , B , Holmstrom , E , Juurmaa , K , Kovarskis , L & Krause , C M 2016 , ' Computer Enabled Neuroplasticity Treatment : A Clinical Trial of a Novel Design for Neurofeedback Therapy in Adult ADHD ' , Frontiers in Human Neuroscience , vol. 10 , 205 . https://doi.org/10.3389/fnhum.2016.00205

Title: Computer Enabled Neuroplasticity Treatment : A Clinical Trial of a Novel Design for Neurofeedback Therapy in Adult ADHD
Author: Cowley, Benjamin; Holmstrom, Edua; Juurmaa, Kristiina; Kovarskis, Levas; Krause, Christina M.
Contributor: University of Helsinki, Behavioural Sciences
University of Helsinki, Behavioural Sciences
University of Helsinki, Behavioural Sciences
University of Helsinki, Behavioural Sciences
Date: 2016-05-09
Language: eng
Number of pages: 13
Belongs to series: Frontiers in Human Neuroscience
ISSN: 1662-5161
URI: http://hdl.handle.net/10138/173548
Abstract: Background: We report a randomized controlled clinical trial of neurofeedback therapy intervention for ADHD/ADD in adults. We focus on internal mechanics of neurofeedback learning, to elucidate the primary role of cortical self-regulation in neurofeedback. We report initial results; more extensive analysis will follow. Methods: Trial has two phases: intervention and follow-up. The intervention consisted of neurofeedback treatment, including intake and outtake measurements, using a waiting-list control group. Treatment involved 40 h-long sessions 2-5 times per week. Training involved either theta/beta or sensorimotor-rhythm regimes, adapted by adding a novel "inverse-training" condition to promote self-regulation. Follow-up (ongoing) will consist of self-report and executive function tests. Setting: Intake and outtake measurements were conducted at University of Helsinki. Treatment was administered at partner clinic Mental Capital Care, Helsinki. Randomization: We randomly allocated half the sample then adaptively allocated the remainder to minimize baseline differences in prognostic variables. Blinding: Waiting-list control design meant trial was not blinded. Participants: Fifty-four adult Finnish participants (mean age 36 years; 29 females) were recruited after screening by psychiatric review. Forty-four had ADHD diagnoses, 10 had ADD. Measurements: Symptoms were assessed by computerized attention test (T.O.V.A.) and self-report scales, at intake and outtake. Performance during neurofeedback trials was recorded. Results: Participants were recruited and completed intake measurements during summer 2012, before assignment to treatment and control, September 2012. Outtake measurements ran April August 2013. After dropouts, 23 treatment and 21 waiting-list participants remained for analysis. Initial analysis showed that, compared to waiting-list control, neurofeedback promoted improvement of self-reported ADHD symptoms, but did not show transfer of learning to T.O.V.A. Comprehensive analysis will be reported elsewhere.
Subject: neurofeedback
attention deficit/hyperactivity disorder
attention deficit disorder
adult
randomized controlled trial
waiting list control
learning curves
learning transfer
ATTENTION-DEFICIT/HYPERACTIVITY DISORDER
DEFICIT-HYPERACTIVITY DISORDER
CONTINUOUS PERFORMANCE-TEST
QUANTITATIVE EEG
STIMULANT-DRUGS
TREATING AD/HD
CHILDREN
BRAIN
METAANALYSIS
SPECIFICITY
515 Psychology
Rights:


Files in this item

Total number of downloads: Loading...

Files Size Format View
Cowley_etal_201 ... lt_ADHD_fnhum_10_00205.pdf 1.959Mb PDF View/Open

This item appears in the following Collection(s)

Show full item record